PARK2 Co-Regulated (PACRG) Peptid
PACRG
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN938543
382,12 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 20 bis 27 Werktagen
Kurzübersicht für PARK2 Co-Regulated (PACRG) Peptid (ABIN938543)
Target
PACRG
(PARK2 Co-Regulated (PACRG))
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- GAIMARCNLD HLGSSDPPTS ASQVAEIIVN SGDGIDYSQQ KRENIGDLIQ
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PACRG antibody,
Alternative Names: PACRG control peptide, PACRG antibody Blocking Peptide, Anti-PACRG Blocking Peptide, Park2 Co-Regulated Blocking Peptide, FLJ32724 Blocking Peptide, GLUP Blocking Peptide, HAK005771 Blocking Peptide, PARK2CRG Blocking Peptide, RP3-495O10.2 Blocking Peptide -
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- PACRG (PARK2 Co-Regulated (PACRG))
-
Hintergrund
- PACRG is a protein that is conserved across metazoans. In vertebrates, this gene is linked in a head-to-head arrangement with the adjacent parkin gene, which is associated with autosomal recessive juvenile Parkinson's disease. These genes are co-regulated in various tissues and they share a bi-directional promoter. Both genes are associated with susceptibility to leprosy.
-
Molekulargewicht
- 33 kDa
Target
-
Sie sind hier:
